phosphorylethanolamine has been researched along with Cardiovascular Diseases in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algarra, M | 1 |
| Gomes, D | 1 |
| Esteves da Silva, JC | 1 |
1 review available for phosphorylethanolamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Current analytical strategies for C-reactive protein quantification in blood.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Ethanolamines; High-Throughput Screening As | 2013 |